164 related articles for article (PubMed ID: 27601162)
21. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
22. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
Zhao R; Masayasu H; Holmgren A
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8579-84. PubMed ID: 12070343
[TBL] [Abstract][Full Text] [Related]
23. Thioredoxin, thioredoxin reductase, and alpha-crystallin revive inactivated glyceraldehyde 3-phosphate dehydrogenase in human aged and cataract lens extracts.
Yan H; Lou MF; Fernando MR; Harding JJ
Mol Vis; 2006 Oct; 12():1153-9. PubMed ID: 17093401
[TBL] [Abstract][Full Text] [Related]
24. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
25. The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila.
Cheng Z; Arscott LD; Ballou DP; Williams CH
Biochemistry; 2007 Jul; 46(26):7875-85. PubMed ID: 17550271
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase.
Wang PF; Marcinkeviciene J; Williams CH; Blanchard JS
Biochemistry; 1998 Nov; 37(46):16378-89. PubMed ID: 9819230
[TBL] [Abstract][Full Text] [Related]
27. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
28. Tissue and plasma thioredoxin reductase expressions in patients with glioblastoma multiforme.
Kemerdere R; Kacira T; Hanimoglu H; Kucur M; Tanriverdi T; Canbaz B
J Neurol Surg A Cent Eur Neurosurg; 2013 Jul; 74(4):234-8. PubMed ID: 23512591
[TBL] [Abstract][Full Text] [Related]
29. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
Söderberg A; Sahaf B; Rosén A
Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
Gan L; Yang XL; Liu Q; Xu HB
J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
[TBL] [Abstract][Full Text] [Related]
33. Role of thioredoxin in lung disease.
Xu J; Li T; Wu H; Xu T
Pulm Pharmacol Ther; 2012 Apr; 25(2):154-62. PubMed ID: 22293327
[TBL] [Abstract][Full Text] [Related]
34. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.
Bellisola G; Fracasso G; Ippoliti R; Menestrina G; Rosén A; Soldà S; Udali S; Tomazzolli R; Tridente G; Colombatti M
Biochem Pharmacol; 2004 May; 67(9):1721-31. PubMed ID: 15081871
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.
Lu J; Vlamis-Gardikas A; Kandasamy K; Zhao R; Gustafsson TN; Engstrand L; Hoffner S; Engman L; Holmgren A
FASEB J; 2013 Apr; 27(4):1394-403. PubMed ID: 23248236
[TBL] [Abstract][Full Text] [Related]
36. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
38. Molecular profiling and functional insights of rock bream (Oplegnathus fasciatus) thioredoxin reductase 3-like molecule: investigation of its transcriptional modulation in response to live pathogen stress.
Elvitigala DA; Whang I; Lee J
Gene; 2015 Oct; 570(1):122-31. PubMed ID: 26055087
[TBL] [Abstract][Full Text] [Related]
39. Thioredoxin reductase.
Mustacich D; Powis G
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):1-8. PubMed ID: 10657232
[TBL] [Abstract][Full Text] [Related]
40. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action.
Liang W; Fernandes AP; Holmgren A; Li X; Zhong L
FEBS J; 2016 Feb; 283(3):446-58. PubMed ID: 26546231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]